Cellectar reports financial results for the second quarter 2021 and provides a corporate update

Florham park, n.j., aug. 09, 2021 (globe newswire) -- cellectar biosciences, inc. (nasdaq: clrb), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced financial results for the second quarter ended june 30, 2021 and provided a corporate update.

CLRB Ratings Summary

CLRB Quant Ranking